They knew about this over 100 years ago. Sunshine used to be the standard treatment for TB. But everyone has to wear toxic sunscreen now. Doctors’ orders.
Vitamin D helps treat lethal drug-resistant TB
Vitamin D has been found to speed up the clearance of tuberculosis (TB) bacteria from the lungs of people with multi-drug resistant TB, according to a study of 1,850 patients receiving antibiotic treatment, led by Queen Mary University of London.
Lead researcher Professor Adrian Martineau from Queen Mary University of London said: “Multi-drug resistant TB is on the rise globally. It’s notoriously difficult to treat, and it carries a much worse prognosis than standard TB.
“Our study raises the possibility that vitamin D – which is very safe and inexpensive – could benefit this hard-to-treat group of patients by taking a novel approach to their treatment. By adding vitamin D to antibiotic treatment, we can boost the immune system to help the body to clear TB bugs, rather than relying on antibiotics on their own to kill the bacteria directly.
“This is a novel approach, as it contrasts with the conventional tactic of developing new antibiotics in an attempt to ‘keep up’ with the emergence of drug-resistant bacteria – an arms race that is proving hard for us to win.”
The World Health Organisation estimates that 10.0 million people developed active tuberculosis in 2017, and that 1.6 million people died of this disease. Multi-drug resistant (MDR) TB is caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB drugs, causing around 500,000 cases and 150,000 deaths per year worldwide. Existing antibiotic treatments for MDR TB are lengthy, costly and often toxic due to their serious side effects.
Vitamin D has shown potential in boosting the immune system, but randomised controlled trials of vitamin D in TB treatment have yielded conflicting results. [my emphasis]
In the new study, published in European Respiratory Journal, the research team pooled data from 1,850 TB patients who took part in clinical trials of vitamin D in eight countries (the UK, Pakistan, Bangladesh, India, Indonesia, Mongolia, Republic of Georgia and Guinea Bissau). They then ran an analysis to see whether there were particular groups of patients who responded better to vitamin D than others.
When added to antibiotic treatment, vitamin D was found to accelerate TB clearance specifically in patients with MDR TB, even though no acceleration of TB clearance was seen when looking at the entire study population as a whole….
The last paragraph seems obvious, given that antibiotics work against non-resistant strains with or without D. That’s why they’re called non-resistant. But it does illustrate how easily this study could have been designed to conceal the importance of D, just by testing all types of TB instead of focusing on MDR TB. If the MDR fraction of the population is sufficiently small, the difference in cure rates between the AB and the AB+D groups would not reach statistical significance.
For another example, they used to commonly make a distinction between early vs late-onset autism, which made the connections with premature cord clamping (early onset autism) and vaccines (late onset autism) hard to miss. Now they no longer routinely distinguish the two types and the statistics aren’t nearly as clear. See:
Getting back to the TB study, they haven’t released the actual paper yet but it would be interesting to know what dosage they used. If history is any guide, it was no more than 2000 IU, which is about 5 minutes in the sun per day for a shirtless caucasian. My guess is they could ditch the antibiotics entirely if they used a normal or reasonably higher than normal dose of D. This seems to be a common technique for suppressing cures while still getting brownie points on your curriculum vita: use therapeutically near-meaningless doses for the experimental group. That way you can generate suggestive statistics and published papers without actually spilling the beans and eliminating an avenue for endless future research. Here’s an example: https://www.nejm.org/doi/full/10.1056/NEJMoa1809944
Seriously, it’s 2019 and they still claim to be unsure about the therapeutic “potential” of normal doses of vitamin D? And we’re supposed to believe this?
As antibiotic resistant infections become more prevalent and our heroic medical establishment invents ever-more toxic concoctions in their endlessly profitable arms-race with devilish microbes (I think my dog DIED from ciprofloxacin antibiotic treatment) at some point the choice will be between medicine and survival.
BTW: inhaled nanosilver (colloidal silver) mist is another broad-spectrum antibacterial and antiviral treatment which, like vitamin D, doesn’t suffer from the antibiotic resistance issue, since its mechanism of action is entirely different. It also has much lower toxicity than antibiotics, in terms of the effective vs toxic dose. And it also works against MDR TB, even when it’s encased in a pointless layer of bovine albumin, apparently added to make the treatment patentable: https://www.researchgate.net/publication/47385607_Nature-inspired_Novel_Drug_Design_Paradigm_Using_Nanosilver_Efficacy_on_Multi-Drug-Resistant_Clinical_Isolates_of_Tuberculosis
It also works against MRSA, which is supposed to be nearly untreatable under conventional medicine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740956/
It may even work against ebola, which is probably why the WHO prevented shipments of CS to africa during an outbreak a few years ago. http://thoughtcrimeradio.net/2017/11/ebola-the-source-and-the-solution/
The biggest problem with CS is that it’s not patentable. In fact you can make it very cheaply at home with electrolysis equipment, although you apparently need specialized equipment to get the optimal particle size of 10 nm.
The existence of these practically zero-cost miracle cures for common respiratory-vectored infections kinda blows the lid off a lot of the vaccine and antibiotic scams.